321 related articles for article (PubMed ID: 26828136)
1. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
[TBL] [Abstract][Full Text] [Related]
2. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma.
Zhang JX; Han L; Bao ZS; Wang YY; Chen LY; Yan W; Yu SZ; Pu PY; Liu N; You YP; Jiang T; Kang CS;
Neuro Oncol; 2013 Dec; 15(12):1595-603. PubMed ID: 24203894
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p.
Cui Y; Yi L; Zhao JZ; Jiang YG
DNA Cell Biol; 2017 Oct; 36(10):822-828. PubMed ID: 28832185
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
Xu C; He T; Li Z; Liu H; Ding B
Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
Yang JX; Liu B; Yang BY; Meng Q
Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
[TBL] [Abstract][Full Text] [Related]
6. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
[TBL] [Abstract][Full Text] [Related]
8. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
Zhao W; Sun C; Cui Z
Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Wang SJ; Wang H; Zhao CD; Li R
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma.
Wu F; Zhang C; Cai J; Yang F; Liang T; Yan X; Wang H; Wang W; Chen J; Jiang T
Oncotarget; 2017 Aug; 8(32):53110-53123. PubMed ID: 28881797
[TBL] [Abstract][Full Text] [Related]
12. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
[TBL] [Abstract][Full Text] [Related]
13. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
14. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
15. HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.
Lu CW; Zhou DD; Xie T; Hao JL; Pant OP; Lu CB; Liu XF
Cancer Med; 2018 Aug; 7(8):3792-3799. PubMed ID: 29992790
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTTIP-Mediated HOXA11 Expression Promotes Cell Growth, Migration and Inhibits Cell Apoptosis in Breast Cancer.
Sun Y; Zeng C; Gan S; Li H; Cheng Y; Chen D; Li R; Zhu W
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415429
[TBL] [Abstract][Full Text] [Related]
17. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma.
Yue H; Zhu J; Xie S; Li F; Xu Q
Biomed Pharmacother; 2016 Jul; 81():203-209. PubMed ID: 27261595
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
Sun M; Nie F; Wang Y; Zhang Z; Hou J; He D; Xie M; Xu L; De W; Wang Z; Wang J
Cancer Res; 2016 Nov; 76(21):6299-6310. PubMed ID: 27651312
[TBL] [Abstract][Full Text] [Related]
19. HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes.
Shi T; Guo D; Xu H; Su G; Chen J; Zhao Z; Shi J; Wedemeyer M; Attenello F; Zhang L; Lu W
Mol Biol Rep; 2020 Apr; 47(4):2723-2733. PubMed ID: 32180085
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA panel as a molecular biomarker in glioma.
Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
